INTERNATIONAL PATENT: ENNOVATE PHARMA, BESNEUX, MATTHIEU FILES APPLICATION FOR "ENGINEERED PROTEIN CONSTRUCTS TARGETING SIGLEC-8 AND CD117"

GENEVA, March 11 -- ENNOVATE PHARMA (15 rue de Hungingue68300 Saint-Louis), BESNEUX, Matthieu (c/o Ennovate Pharma15 rue de Hungingue68300 Saint-Louis) filed a patent application (PCT/US2025/044059) for "ENGINEERED PROTEIN CONSTRUCTS TARGETING SIGLEC-8 AND CD117" on Aug 28, 2025. With publication no. WO/2026/050570, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOUCHEZ, Laure C. (c/o Ennovate Pharma15 rue de Hungingue68300 Saint-Louis), ARENA DE SOUZA, Victoria (c/o Ennovate Pharma15 rue de Hungingue68300 Saint-Louis), ...